Mesa Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Mesa Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Mesa Laboratories, Inc. MLAB.OQ reported quarterly adjusted earnings of 75 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 45 cents. The mean expectation of two analysts for the quarter was for earnings of 36 cents per share. Wall Street expected results to range from 29 cents to 43 cents per share.
Revenue rose 2.6% to $62.34 million from a year ago; analysts expected $62.20 million.
Mesa Laboratories, Inc.'s reported EPS for the quarter was 75 cents.
The company reported quarterly net income of $4.34 million.
Mesa Laboratories, Inc. shares had fallen by 1.3% this quarter and gained 63.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 24.1% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Mesa Laboratories, Inc. is $125.00, about 2.6% below its last closing price of $128.25
This summary was machine generated from LSEG data November 9 at 10:39 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.36 | 0.75 | Beat |
Jun. 30 2026 | 0.03 | 0.49 | Beat |
Mar. 31 2026 | 0.34 | -0.75 | Missed |
Dec. 31 2025 | 0.28 | 0.65 | Beat |
Recent news on Mesa Laboratories
See all newsMesa Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Mesa Laboratories Q2 revenue rises on divisional performance
Mesa Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Mesa Labs Q1 revenue rises as calibration, biopharma units grow
Mesa Laboratories, Inc. expected to post earnings of 3 cents a share - Earnings Preview